Literature DB >> 20206635

Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling.

Neeta Adhikari1, David L Basi, Dewayne Townsend, Melissa Rusch, Ami Mariash, Sureni Mullegama, Adrienne Watson, Jon Larson, Sara Tan, Ben Lerman, Jeffrey D Esko, Scott B Selleck, Jennifer L Hall.   

Abstract

Heparan sulfate proteoglycans are abundant molecules in the extracellular matrix and at the cell surface. Heparan sulfate chains are composed of groups of disaccharides whose side chains are modified through a series of enzymatic reactions. Deletion of these enzymes alters heparan sulfate fine structure and leads to changes in cell proliferation and tissue development. The role of heparan sulfate modification has not been explored in the vessel wall. The goal of this study was to test the hypothesis that altering heparan sulfate fine structure would impact vascular smooth muscle cell (VSMC) proliferation, vessel structure, and remodeling in response to injury. A heparan sulfate modifying enzyme, N-deacetylase N-sulfotransferase1 (Ndst1) was deleted in smooth muscle resulting in decreased N- and 2-O sulfation of the heparan sulfate chains. Smooth muscle specific deletion of Ndst1 led to a decrease in proliferating VSMCs and the circumference of the femoral artery in neonatal and adult mice. In response to vascular injury, mice lacking Ndst1 exhibited a significant reduction in lesion formation. Taken together, these data provide new evidence that modification of heparan sulfate fine structure through deletion of Ndst1 is sufficient to decrease VSMC proliferation and alter vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206635      PMCID: PMC2885463          DOI: 10.1016/j.yjmcc.2010.02.022

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  41 in total

Review 1.  Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics.

Authors:  S B Selleck
Journal:  Trends Genet       Date:  2000-05       Impact factor: 11.639

Review 2.  Molecular diversity of heparan sulfate.

Authors:  J D Esko; U Lindahl
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 3.  Heparan sulfate: lessons from knockout mice.

Authors:  E Forsberg; L Kjellén
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 4.  Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Authors:  Jeffrey D Esko; Scott B Selleck
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

5.  Structural analysis of glycosaminoglycans in animals bearing mutations in sugarless, sulfateless, and tout-velu. Drosophila homologues of vertebrate genes encoding glycosaminoglycan biosynthetic enzymes.

Authors:  H Toyoda; A Kinoshita-Toyoda; B Fox; S B Selleck
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

6.  Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1.

Authors:  M Ringvall; J Ledin; K Holmborn; T van Kuppevelt; F Ellin; I Eriksson; A M Olofsson; L Kjellen; E Forsberg
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

7.  A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia.

Authors:  M Sata; Y Maejima; F Adachi; K Fukino; A Saiura; S Sugiura; T Aoyagi; Y Imai; H Kurihara; K Kimura; M Omata; M Makuuchi; Y Hirata; R Nagai
Journal:  J Mol Cell Cardiol       Date:  2000-11       Impact factor: 5.000

8.  A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling.

Authors:  Xiaohong Wang; Yan Xiao; Yongshan Mou; Ying Zhao; W Matthijs Blankesteijn; Jennifer L Hall
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

Review 9.  The sweet and sour of cancer: glycans as novel therapeutic targets.

Authors:  Mark M Fuster; Jeffrey D Esko
Journal:  Nat Rev Cancer       Date:  2005-07       Impact factor: 60.716

10.  Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.

Authors:  Kristina Skålén; Maria Gustafsson; Ellen Knutsen Rydberg; Lillemor Mattsson Hultén; Olov Wiklund; Thomas L Innerarity; Jan Borén
Journal:  Nature       Date:  2002-06-13       Impact factor: 49.962

View more
  13 in total

1.  Heparan sulfate expression in the neural crest is essential for mouse cardiogenesis.

Authors:  Yi Pan; Christian Carbe; Sabine Kupich; Ute Pickhinke; Stefanie Ohlig; Maike Frye; Ruth Seelige; Srinivas R Pallerla; Anne M Moon; Roger Lawrence; Jeffrey D Esko; Xin Zhang; Kay Grobe
Journal:  Matrix Biol       Date:  2013-11-05       Impact factor: 11.583

2.  Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.

Authors:  Youming Guo; Pengfei Li; Grant Bledsoe; Zhi-Rong Yang; Lee Chao; Julie Chao
Journal:  Exp Cell Res       Date:  2015-07-05       Impact factor: 3.905

3.  MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA).

Authors:  Zsolt Kasza; Peder Fredlund Fuchs; Christoffer Tamm; Anna S Eriksson; Paul O'Callaghan; Femke Heindryckx; Dorothe Spillmann; Erik Larsson; Sébastien Le Jan; Inger Eriksson; Pär Gerwins; Lena Kjellén; Johan Kreuger
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

4.  Smooth muscle specific deletion of Ndst1 leads to decreased vessel luminal area and no change in blood pressure in conscious mice.

Authors:  Kim Ramil C Montaniel; Marie Billaud; Cassandra Graham; Sun K Kim; Marjorie Carlson; William Zeng; Orien Zeng; Wei Pan; Brant E Isakson; Jennifer L Hall; Neeta Adhikari
Journal:  J Cardiovasc Transl Res       Date:  2012-05-04       Impact factor: 4.132

Review 5.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

6.  Changes in expression of proteoglycan core proteins and heparan sulfate enzymes in the developing and adult murine aorta.

Authors:  Neeta Adhikari; Marjorie Carlson; Ben Lerman; Jennifer L Hall
Journal:  J Cardiovasc Transl Res       Date:  2011-04-06       Impact factor: 4.132

Review 7.  The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.

Authors:  Kevin J McCarthy; Deborah J Wassenhove-McCarthy
Journal:  Microsc Microanal       Date:  2012-02       Impact factor: 4.127

8.  Vascular biomechanical properties in mice with smooth muscle specific deletion of Ndst1.

Authors:  Neeta Adhikari; Marie Billaud; Marjorie Carlson; Spencer P Lake; Kim Ramil C Montaniel; Rod Staggs; Weihua Guan; Dinesha Walek; Snider Desir; Brant E Isakson; Victor H Barocas; Jennifer L Hall
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

9.  Chromosome 2 Fragment Substitutions in Dahl Salt-Sensitive Rats and RNA Sequencing Identified Enpep and Hs2st1 as Vascular Inflammatory Modulators.

Authors:  Olga Berillo; Sofiane Ouerd; Noureddine Idris-Khodja; Asia Rehman; Chantal Richer; Daniel Sinnett; Anne E Kwitek; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2020-11-09       Impact factor: 10.190

10.  A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis.

Authors:  Xin Yin; Jadwiga Truty; Roger Lawrence; Scott C Johns; R Sathish Srinivasan; Tracy M Handel; Mark M Fuster
Journal:  Mol Cancer       Date:  2010-12-20       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.